Literature DB >> 6863500

Enzyme-linked immunosorbent assay for detection of measles antibody.

W L Boteler, P M Luipersbeck, D A Fuccillo, A J O'Beirne.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of measles immunoglobulin G antibody (MEASELISA). This assay was found to be comparable to the measles hemagglutination inhibition (HAI) test. Approximately 500 sera from three centers were tested by MEASELISA and the HAI test. MEASELISA demonstrated values of greater than 99% for sensitivity, specificity, and accuracy. Values were very precise, with a mean coefficient of variation of 5.4%. MEASELISA values were shown by linear regression analysis to increase as HAI titers increased. A coefficient of determination of 1.00 was obtained from test center three. MEASELISA values were found to be linearly related (r2 greater than 0.97) to MEASELISA titers, thus enabling quantitation of measles antibody from a single value. Also, data are presented that show MEASELISA to be equivalent to complement fixation for evaluating paired sera for the presence of a significant increase in antibody levels to measles virus.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6863500      PMCID： PMC272746          DOI： 10.1128/jcm.17.5.814-818.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  METHODS OF DETERMINING IMMUNITY, DURATION AND CHARACTER OF IMMUNITY RESULTING FROM MEASLES.

Authors:  G ENDERS-RUCKLE
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

Review 3.  Heterogeneous enzyme immunoassay.

Authors:  A J O'Beirne; H R Cooper
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

Review 4.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

5.  Comparison of enzyme-linked immunosorbent assay for acute measles with hemagglutination inhibition complement fixation, and fluorescent-antibody methods.

Authors:  M B Kleiman; C K Blackburn; S E Zimmerman; M L French
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

6.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

7.  Low level rubella immunity detected by ELISA and specific lymphocyte transformation.

Authors:  E Buimovici-Klein; A J O'Beirne; S J Millian; L Z Cooper
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Detection of IgG antibodies specific for measles virus by enzyme-linked immunosorbent assay (ELISA).

Authors:  S Kahane; V Goldstein; I Sarov
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

9.  Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies.

Authors:  B Forghani; N J Schmidt
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948
  9 in total
  10 in total

1.  Response to measles-mumps-rubella vaccine in children on dialysis.

Authors:  S L Schulman; A Deforest; B A Kaiser; M S Polinsky; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

2.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.

Authors:  J P Struewing; K C Hyams; J E Tueller; G C Gray
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

4.  Multicenter evaluation of a 1-h enzyme-linked immunosorbent assay for rubella serology.

Authors:  W L Boteler; K J Barnes; E Buimovici-Klein; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

5.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

Authors:  K A Weigle; M D Murphy; P A Brunell
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

7.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.

Authors:  N Dhiman; I G Ovsyannikova; R A Vierkant; V S Pankratz; R M Jacobson; G A Poland
Journal:  Tissue Antigens       Date:  2008-09

9.  Evaluation of hemagglutinin protein-specific immunoglobulin M for diagnosis of measles by an enzyme-linked immunosorbent assay based on recombinant protein produced in a high-efficiency mammalian expression system.

Authors:  F B Bouche; N H Brons; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

10.  Detection and titration of measles virus antibody by hemagglutination inhibition and by dot immunobinding.

Authors:  S S Kalter; R L Heberling; J D Barry
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.